APPLICATION
ANDA090092
TYPE
ANDA
ORIGINAL APPROVAL
2008-04-25
LATEST ACTION
2020-02-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
ZIDOVUDINEPrescription
ZIDOVUDINE 300MG · TABLET · ORAL
Approval history
2020-02-10Labeling · Supplement 8 · standardAP
2020-02-10Labeling · Supplement 6 · standardAP
2020-02-10Labeling · Supplement 9 · standardAP
2010-02-25Labeling · Supplement 2AP
2009-03-05Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.